<DOC>
	<DOCNO>NCT00025610</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness different combination chemotherapy regimens treat infant newly diagnose neuroblastoma .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Infants With Newly Diagnosed Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : - Confirm outcome infant newly diagnose stage IV IVS neuroblastoma without MYCN amplification alter treatment etoposide carboplatin follow cyclophosphamide , doxorubicin , vincristine . - Determine whether deletion chromosome 1p diploidy/tetraploidy prognostic factor patient . - Determine whether prognostic criterion could use future therapeutic stratification patient . OUTLINE : This multicenter study . Patients stratify accord age ( 1 month vs 1 month ) . Infants less 1 month age stratify accord Philadelphia score ( le 1 v least 1 ) . Infants 1 month age also stratify accord Philadelphia score ( le 2 v least 2 ) . Infants 1 month age Philadelphia score le 1 infant 1 month age Philadelphia score le 2 undergo observation . Infants 1 month age Philadelphia score least 1 infant 1 month age Philadelphia score least 2 receive VP-CARBO chemotherapy . - VP-CARBO chemotherapy : Patients receive etoposide IV 2 hour carboplatin IV 1 hour day 1-3 . Treatment repeat every 21 day 2 course . Patients response receive CADO chemotherapy . - CADO chemotherapy : Patients receive cyclophosphamide IV 1 hour day 1-5 , doxorubicin IV 6 hour day 4 5 , vincristine IV day 1 5 . Treatment repeat every 21 day maximum 4 course . Patients follow within 6 month annually 5 year . PROJECTED ACCRUAL : A total 130 patient accrue study within 4 year .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm newly diagnose stage IV IVS neuroblastoma ganglioneuroblastoma Metastases confined marrow , skin , node , liver No metastasis bone ( radiologic bone lesion skeleton ) , CNS , pleura , lung No MYCN amplification ( i.e. , few 10 copy ) PATIENT CHARACTERISTICS : Age : Under 12 month diagnosis Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>November 2001</verification_date>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
</DOC>